• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 548906 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414175839 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414175839 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Cytori Therapeutics, Shares Down 5.7% (CYTX)

Published on Fri, 08/09/2013 - 12:38
By Peter Chu

Cytori Therapeutics (NASDAQ:CYTX) is one of today's worst performing low-priced stocks, down 5.7% to $2.50 on 1.3x average daily volume. Cytori Therapeutics has traded 281,000 shares thus far today, vs. average volume of 211,000 shares per day. The stock has underperformed the Dow (-5.7% to the Dow's -0.6%) and underperformed the S&P 500 (-5.7% to the S&P's -0.3%) during today's trading.

Cytori Therapeutics, Inc. discovers and develops cell-based therapeutics utilizing adult stem cells derived from fat tissue. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery.

Over the past year, Cytori Therapeutics has traded in a range of $2.20 to $4.93 and is now at $2.50, 14% above that low. The 200-day and 50-day moving averages have moved 1.18% lower and 0.47% higher over the past week, respectively.

Cytori Therapeutics (NASDAQ:CYTX) has potential upside of 165.0% based on a current price of $2.50 and analysts' consensus price target of $6.62. Cytori Therapeutics shares should encounter resistance at the 200-day moving average (MA) of $2.82 and support at the 50-day MA of $2.49.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Trading Higher on Heavy Volume are Share...

Shares of Phillips-Van Heusen are trading today in above average volume, with the share ...

Volume Spike Detected in Shares of SVB F...

Shares of SVB Financial are trading down 3.2% to $102.61 today on above average volume. ...

W&T Offshore Makes a Move: Down 1.4%...

W&T Offshore (NYSE:WTI), a company whose shares are moving quickly, is trading 1.4% low ...

Ingram Micro's Shares Changing Hands at ...

Shares of Ingram Micro are trading today in above average volume, with the share price ...

Stock Investors Bid Up Shares of Microch...

Microchip Technology (NASDAQ:MCHP) is a company whose shares are active, trading 1.4% h ...

Informatica's Shares Changing Hands at H...

Shares of Informatica are trading today in above average volume, with the share price r ...

Stock Investors Bid Up Shares of Progres...

One of today's notable stocks on the rise is Progressive (NYSE:PGR), up 1.4% to $25.79. ...

Volume Spike Detected in Shares of Avery...

Shares of Avery Dennison are trading today in above average volume, with the share pric ...